Wengui Shi

9PUBLICATIONS
53CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Cancer diagnosisCancer cell biologyChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 23, 2026
Non-kinase Orchestrated VEGFR2-ERK Signaling is a Dependency and Pharmacological Target for Antiangiogenic Immunotherapy.

|May 04, 2026
Midbody Remnants as Signaling Centers in Cell Fate Determination and Tumorigenesis.

|Nov 06, 2025
USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Coevolution in Pancreatic Cancer.

Xiangyan Jiang, Bin Zhao, Tao Wang

|Sep 23, 2024
Targeting SHCBP1 Inhibits Tumor Progression by Restoring Ciliogenesis in Ductal Carcinoma.

Wengui Shi, Lianshun Li, Huiming Zhao

|Jan 12, 2024
SHCBP1 Overexpression Aggravates Pancreatitis by Triggering the Loss of Primary Cilia.

Lianshun Li, Huiming Zhao, Zhengyang Li

|Aug 30, 2023
PICH Activates Cyclin A1 Transcription to Drive S-Phase Progression and Chemoresistance in Gastric Cancer.

Huili Ye, Wengui Shi, Jing Yang

Pageof 2

Frequent Collaborators

6 joint publications

Zuoyi Jiao

5 joint publications

Long Qin

4 joint publications

Huinian Zhou

4 joint publications

Zeyuan Yu